Literature DB >> 26264836

Multistage vector (MSV) therapeutics.

Joy Wolfram1, Haifa Shen2, Mauro Ferrari3.   

Abstract

One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological barriers; Cancer therapy; Geometrical targeting; Porous silicon; Transport oncophysics

Mesh:

Year:  2015        PMID: 26264836      PMCID: PMC4656100          DOI: 10.1016/j.jconrel.2015.08.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  126 in total

Review 1.  Molecular imaging applications in nanomedicine.

Authors:  King C P Li; Sunil D Pandit; Samira Guccione; Mark D Bednarski
Journal:  Biomed Microdevices       Date:  2004-06       Impact factor: 2.838

Review 2.  Intravascular delivery of particulate systems: does geometry really matter?

Authors:  Paolo Decuzzi; Renata Pasqualini; Wadih Arap; Mauro Ferrari
Journal:  Pharm Res       Date:  2008-08-20       Impact factor: 4.200

Review 3.  RGD and other recognition sequences for integrins.

Authors:  E Ruoslahti
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

4.  Sustained small interfering RNA delivery by mesoporous silicon particles.

Authors:  Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian M K Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

5.  Revisit complexation between DNA and polyethylenimine - Effect of uncomplexed chains free in the solution mixture on gene transfection.

Authors:  Yanan Yue; Fan Jin; Rui Deng; Jinge Cai; Yangchao Chen; Marie C M Lin; Hsiang-Fu Kung; Chi Wu
Journal:  J Control Release       Date:  2010-11-03       Impact factor: 9.776

Review 6.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

7.  Dietary silicon intake and absorption.

Authors:  Ravin Jugdaohsingh; Simon H C Anderson; Katherine L Tucker; Hazel Elliott; Douglas P Kiel; Richard P H Thompson; Jonathan J Powell
Journal:  Am J Clin Nutr       Date:  2002-05       Impact factor: 7.045

8.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

9.  Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.

Authors:  Bhuvanesh Dave; Sergio Granados-Principal; Rui Zhu; Stephen Benz; Shahrooz Rabizadeh; Patrick Soon-Shiong; Ke-Da Yu; Zhimin Shao; Xiaoxian Li; Michael Gilcrease; Zhao Lai; Yidong Chen; Tim H-M Huang; Haifa Shen; Xuewu Liu; Mauro Ferrari; Ming Zhan; Stephen T C Wong; Muthiah Kumaraswami; Vivek Mittal; Xi Chen; Steven S Gross; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-29       Impact factor: 11.205

10.  Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues.

Authors:  Adi Tzur-Balter; Zohar Shatsberg; Margarita Beckerman; Ester Segal; Natalie Artzi
Journal:  Nat Commun       Date:  2015-02-11       Impact factor: 14.919

View more
  19 in total

1.  A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.

Authors:  Bronwyn Scott; Jianliang Shen; Sara Nizzero; Kathryn Boom; Stefano Persano; Yu Mi; Xuewu Liu; Yuliang Zhao; Elvin Blanco; Haifa Shen; Mauro Ferrari; Joy Wolfram
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

2.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

3.  A Micro/Nano Composite for Combination Treatment of Melanoma Lung Metastasis.

Authors:  Yu Mi; Chaofeng Mu; Joy Wolfram; Zaian Deng; Tony Ye Hu; Xuewu Liu; Elvin Blanco; Haifa Shen; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2016-02-18       Impact factor: 9.933

Review 4.  Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.

Authors:  Sara Busatto; Anthony Pham; Annie Suh; Shane Shapiro; Joy Wolfram
Journal:  Biomed Microdevices       Date:  2019-04-15       Impact factor: 2.838

5.  Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.

Authors:  Carlotta Borsoi; Fransisca Leonard; Yeonju Lee; Mohamed Zaid; Dalia Elganainy; Jenolyn Francisca Alexander; Megumi Kai; Yan Ting Liu; Yaan Kang; Xuewu Liu; Eugene J Koay; Mauro Ferrari; Biana Godin; Kenji Yokoi
Journal:  Cancer Lett       Date:  2017-07-04       Impact factor: 8.679

Review 6.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

7.  Enzyme-responsive multistage vector for drug delivery to tumor tissue.

Authors:  Yu Mi; Joy Wolfram; Chaofeng Mu; Xuewu Liu; Elvin Blanco; Haifa Shen; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2016-08-19       Impact factor: 7.658

Review 8.  The Emerging Role of Nanotechnology in Cell and Organ Transplantation.

Authors:  Ennio Tasciotti; Fernando J Cabrera; Michael Evangelopoulos; Jonathan O Martinez; Usha R Thekkedath; Malgorzata Kloc; Rafik M Ghobrial; Xian C Li; Alessandro Grattoni; Mauro Ferrari
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

9.  Post-nano strategies for drug delivery: Multistage porous silicon microvectors.

Authors:  Alessandro Venuta; Joy Wolfram; Haifa Shen; Mauro Ferrari
Journal:  J Mater Chem B       Date:  2016-11-26       Impact factor: 6.331

10.  Cell source determines the immunological impact of biomimetic nanoparticles.

Authors:  Michael Evangelopoulos; Alessandro Parodi; Jonathan O Martinez; Iman K Yazdi; Armando Cevenini; Anne L van de Ven; Nicoletta Quattrocchi; Christian Boada; Nima Taghipour; Claudia Corbo; Brandon S Brown; Shilpa Scaria; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.